Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-02-17 @ 7:14 PM
Study NCT ID:
NCT02809469
Status:
UNKNOWN
Last Update Posted:
2016-06-22
First Post:
2016-06-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apixaban Dose Reduction in Patients With Elevated Drug Levels
Sponsor:
Hamilton Health Sciences Corporation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ADREL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |